96 filings
Page 3 of 5
S-8
dsl96u01u
2 Mar 23
Registration of securities for employees
4:52pm
8-K
nk6h52v
2 Mar 23
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives
4:10pm
8-K
q6cid 8bpv
8 Feb 23
Other Events
5:02pm
424B5
zvalzmy
8 Feb 23
Prospectus supplement for primary offering
4:06pm
424B5
i6au55oz
7 Feb 23
Prospectus supplement for primary offering
4:40pm
8-K
lmu3rzq3meyk0a
7 Feb 23
Results of Operations and Financial Condition
4:10pm
8-K
ecldbf4qb2cjbaorc45c
5 Dec 22
Regulation FD Disclosure
8:45am
8-K
4cfts
3 Nov 22
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
8:46am
EFFECT
xqihf
12 Oct 22
Notice of effectiveness
12:15am
CORRESP
i0gfhe4g v0
5 Oct 22
Correspondence with SEC
12:00am
UPLOAD
3vzx8 9xgrcy9
3 Oct 22
Letter from SEC
12:00am
S-3
yyql j6eld
30 Sep 22
Shelf registration
4:11pm
8-K
u2wwu2olbae6wd8s7
19 Sep 22
Entry into a Material Definitive Agreement
4:08pm
8-K
32cf02a5 my4m
4 Aug 22
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:19pm
8-K
o34es kelfe
24 May 22
Submission of Matters to a Vote of Security Holders
4:21pm
8-K
tce0ozgj nr9vkka6vue
5 May 22
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
12:00am